|
⚲
|
| Keyboard |
| Growth Equity Opportunities V LLC
✚
|
|
|---|---|
| CIK # | 0001706444 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001706444] | |
| 4 | [0001706444] | |
| SC 13D | [0001706444] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| NEA Partners 16 LP | |
| New Enterprise Associates 16 LP | |
| Regulus Therapeutics Inc | |
| Growth Equity Opportunities V LLC | |
| NEA 16 GP LLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Regulus Therapeutics Inc RGLS
Class A-3 Convertible Preferred Stock · derivative
|
2020-12-04 | Buy | 258,707 | $6.22 | 1,609,158 |
|
Regulus Therapeutics Inc RGLS
Common Stock
|
2020-12-04 | Buy | 4,398,602 | $0.62 | 2,727,133 |
|
Regulus Therapeutics Inc RGLS
Common Stock Purchase Warrant (right to buy) · derivative
|
2020-12-04 | Buy | 5,239,254 | $0.13 | 681,103 |
|
Regulus Therapeutics Inc RGLS
Class A-2 Convertible Preferred Stock · derivative
|
2019-12-24 | Buy | 900,900 | $6.66 | 5,999,994 |
|
Regulus Therapeutics Inc RGLS
Common Stock Purchase Warrant (Right to Buy) · derivative
|
2019-12-24 | Buy | 9,009,000 | $0.13 | 1,171,170 |
|
Regulus Therapeutics Inc RGLS
Common Stock
|
2019-05-07 | Buy | 1,136,704 | $1.08 | 1,227,640 |
|
Regulus Therapeutics Inc RGLS
Class A-1 Convertible Preferred Stock · derivative
|
2019-05-07 | Buy | 256,700 | $10.80 | 2,772,360 |
|
Regulus Therapeutics Inc RGLS
Common Stock Purchase Warrant (Right to Buy) · derivative
|
2019-05-07 | Buy | 3,703,704 | $0.13 | 481,482 |